News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
MetLife Acquires PineBridge's Non-CN Assets for US$800M; Pacific Century Group Retains CN Operations
PCCW (00008.HK) Chairman Richard Li's Pacific Century Group has sold PineBridge Investments' assets outside mainland China to MetLife Investment Management for US$800 milli...
Reset
Send
The window will close in 5 seconds
MetLife Acquires PineBridge's Non-CN Assets for US$800M; Pacific Century Group Retains CN Operations
Close
Recommend
8
Positive
20
Negative
10
 
SHORT SELL
 
STOCK INFO

PCCW (00008.HK)  +0.040 (+0.879%)    Short selling $6.14M; Ratio 10.183%   Chairman Richard Li's Pacific Century Group has sold PineBridge Investments' assets outside mainland China to MetLife Investment Management for US$800 million in cash. The transaction is expected to be completed next year.

In addition, based on PineBridge's financial metrics for 2025 and subsequent years, the transaction price could reach up to US$1.2 billion (around $9.3 billion). The transaction excludes PineBridge's joint ventures and private equity business in China.

Related NewsJPM Cuts TPs for HTSC/ CICC as Sector Top Picks
In response to this transaction, Pacific Century Group said that looking ahead, the group has strategically retained its mainland China business and will focus on advancing its core strengths through the development of Huatai-PineBridge and a uniquely positioned private fund business.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-03-25 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.